ViAqua Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10M
- Investors
-
12
ViAqua Therapeutics General Information
Description
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics in aquaculture. The company's platform utilizes a proprietary RNAi nanoparticle formulation that triggers a cellular reaction to disable the viral infection via feed or immersion, enabling aquaculture industries to improve resistance against viral diseases that attack shrimp and other species.
Contact Information
Website
www.viaqua-t.comCorporate Office
- Gutwirth Park
- Technion City
- Haifa 3200003
- Israel
Corporate Office
- Gutwirth Park
- Technion City
- Haifa 3200003
- Israel
ViAqua Therapeutics Timeline
ViAqua Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 05-Sep-2023 | $10M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 09-Jun-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 18-Dec-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 04-Jul-2018 | $290K | $290K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
ViAqua Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Shares | ||||||||
| A-1 Shares | ||||||||
| Seed Shares | 56,000 | $0.010000 | $53.83 | $53.83 | 1x | $53.83 | 6.21% | |
| Seed-1 Shares | 7,000 | $0.010000 | $43.07 | $43.07 | 1x | $43.07 | 0.75% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ViAqua Therapeutics Comparisons
Industry
Financing
Details
ViAqua Therapeutics Competitors (1)
One of ViAqua Therapeutics’s competitors is ViroVet, a Venture Capital-Backed company based in Leuven, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ViroVet | Venture Capital-Backed | Leuven, Belgium |
ViAqua Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ViAqua Therapeutics Patents
ViAqua Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190175518-A1 | Compositions and methods for treating viral infections in shrimps | Active | 26-Apr-2016 | ||
| US-10973774-B2 | Compositions and methods for treating viral infections in shrimps | Active | 26-Apr-2016 |
ViAqua Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ViAqua Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Circle Investments LLC | Venture Capital | Minority | ||
| I-Lab Angels | Angel Group | Minority | ||
| Rabo Ventures | Venture Capital | Minority | ||
| Agronetto | Corporation | Minority | ||
| S2G Investments | Venture Capital | Minority |
ViAqua Therapeutics FAQs
-
When was ViAqua Therapeutics founded?
ViAqua Therapeutics was founded in 2014.
-
Where is ViAqua Therapeutics headquartered?
ViAqua Therapeutics is headquartered in Haifa, Israel.
-
What is the size of ViAqua Therapeutics?
ViAqua Therapeutics has 13 total employees.
-
What industry is ViAqua Therapeutics in?
ViAqua Therapeutics’s primary industry is Biotechnology.
-
Is ViAqua Therapeutics a private or public company?
ViAqua Therapeutics is a Private company.
-
What is the current valuation of ViAqua Therapeutics?
The current valuation of ViAqua Therapeutics is .
-
What is ViAqua Therapeutics’s current revenue?
The current revenue for ViAqua Therapeutics is .
-
How much funding has ViAqua Therapeutics raised over time?
ViAqua Therapeutics has raised $17.6M.
-
Who are ViAqua Therapeutics’s investors?
Circle Investments LLC, I-Lab Angels, Rabo Ventures, Agronetto, and S2G Investments are 5 of 12 investors who have invested in ViAqua Therapeutics.
-
Who are ViAqua Therapeutics’s competitors?
ViroVet is a competitor of ViAqua Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
